Studysummary This article outlines management guidelines for androgenetic alopecia, highlighting that continued treatment with medications like finasteride or minoxidil typically halts progression and improves hair condition in most mild to moderate cases.
Read the full study on onlinelibrary.wiley.com →
Research cited in this study 25
- Finasteride in the Treatment of Men with Frontal Male Pattern Hair Loss Journal of The American Academy of Dermatology · 1999
- Expression of Vascular Endothelial Growth Factor (VEGF) in Various Compartments of the Human Hair Follicle Archives of Dermatological Research · 1998
- Finasteride in the Treatment of Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1998
- Male Pattern Hair Loss: Current Understanding International Journal of Dermatology · 1998
- 5α-Reductase Activity in the Human Hair Follicle Concentrates in the Dermal Papilla Archives of Dermatological Research · 1998
- Minoxidil Upregulates the Expression of Vascular Endothelial Growth Factor in Human Hair Dermal Papilla Cells British Journal of Dermatology · 1998
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells: Evidence of Its Presence in Melanocytes Journal of Investigative Dermatology · 1998
- Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia Journal of Investigative Dermatology · 1997
- Diffuse Hypertrichosis During Treatment with 5% Topical Minoxidil British Journal of Dermatology · 1997
- Guidelines of Care for Androgenetic Alopecia Journal of The American Academy of Dermatology · 1996
- The 5 Alpha-Reductase System and Its Inhibitors Dermatology · 1996
- The Effects of Finasteride (Proscar) on Hair Growth, Hair Cycle Stage, and Serum Testosterone and Dihydrotestosterone in Adult Male and Female Stumptail Macaques (Macaca Arctoides) The Journal of Clinical Endocrinology and Metabolism · 1994
- The Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Scalp Skin Testosterone and Dihydrotestosterone Concentrations in Patients With Male Pattern Baldness The Journal of Clinical Endocrinology and Metabolism · 1994
- Androgenetic Alopecia in the Female: Treatment with 2% Topical Minoxidil Solution Archives of Dermatology · 1994
- Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993
- Diagnostic and Predictive Value of Horizontal Sections of Scalp Biopsy Specimens in Male Pattern Androgenetic Alopecia Journal of The American Academy of Dermatology · 1993
- The Importance of Adequate Serum Ferritin Levels During Oral Cyproterone Acetate and Ethinyl Estradiol Treatment of Diffuse Androgen-Dependent Alopecia in Women Clinical Endocrinology · 1992
- Natural Progression of Male Pattern Baldness in Young Men Clinical and Experimental Dermatology · 1991
- Contact Dermatitis Caused By Topical Minoxidil: Case Reports And Review Of The Literature American Journal of Contact Dermatitis · 1991
- Patterned Androgenic Alopecia in Women Journal of The American Academy of Dermatology · 1988
- Topical Tretinoin for Hair Growth Promotion Journal of the American Academy of Dermatology · 1986
- Oral Spironolactone Therapy for Female Patients with Acne, Hirsutism, or Androgenic Alopecia British Journal of Dermatology · 1985
- The Inheritance Of Common Baldness: To Be Or Not To Be? Journal of the American Academy of Dermatology · 1984
- Treatment of Hirsutism, Acne, and Alopecia with Cyproterone Acetate Dermatology · 1980
- Classification of the Types of Androgenetic Alopecia (Common Baldness) Occurring in the Female Sex British Journal of Dermatology · 1977